Risk of Osteoporotic Fractures after Thyroid-stimulating Hormone Suppression Therapy in Patients with Thyroid Cancer

BACKGROUND: The effects of subclinical hyperthyroidism on fracture risk induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with thyroid cancer still remains controversial. We performed a meta-analysis and systematic review to evaluate the effects of TSH suppression therapy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Bone Metab
Egile Nagusiak: Lee, Youjin, Yoon, Byung-Ho, Lee, Seeyoun, Chung, Youn Kyung, Lee, Young-Kyun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Society for Bone and Mineral Research 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6416149/
https://ncbi.nlm.nih.gov/pubmed/30899724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2019.26.1.45
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak